Shire buys Lumena Pharma for at least $260 mln
[Reuters – UK Focus] – * Shire (LSE: SHP.L – news) says deal boosts rare diseases portfolio * Lumena received multiple approaches * Says Shire will help it take liver drugs to market (Adds detail, Lumena CEO comments) LONDON, May 12 (Reuters) – London-li more
View todays social media effects on GCVRZ
View the latest stocks trending across Twitter. Click to view dashboard